1.
Todorović Balint M, Bila J, Balint B, Jeličić J, Djunić I, Antić D, et al. Influence of applied CD34+ cell dose on the survival of Hodgkin’s lymphoma and multiple myeloma patients following autologous stem cell transplants. Vojnosanit Pregl [Internet]. 2021 Apr. 7 [cited 2026 Jul. 12];77(8). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/18536